Related Experiment Video
Updated: May 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
"It's my secret": barriers to paediatric HIV treatment in a poor rural South African setting
E W Kimani-Murage1, L Manderson, S A Norris
1African Population and Health Research Center, Nairobi, Kenya. lizmurage@gmail.com
Insights
Barriers to pediatric HIV care in rural South Africa include stigma, misconceptions, and poor healthcare access. Addressing these requires community interventions and improved healthcare professional training to increase anti-retroviral therapy coverage.
Area of Science:
- Public Health
- Pediatric HIV/AIDS
- Qualitative Research
Background:
- A significant proportion of children in South Africa are born exposed to HIV, with low rates of confirmatory testing and anti-retroviral therapy (ART) coverage.
- The national ART program in South Africa, initiated in 2004, has not achieved adequate ART coverage among children.
Purpose of the Study:
- To investigate critical barriers preventing children in rural South Africa from accessing HIV-related care.
- To understand the factors influencing delayed treatment-seeking for pediatric HIV.
Main Methods:
- Community-based qualitative research conducted in poor rural villages in north-east South Africa.
- 21 in-depth interviews with caregivers of HIV-positive children (identified in 2007) were conducted in 2008.
- Data analysis employed NVIVO 8 and a constant comparative method to identify themes.
Main Results:
- Structural, social, and systemic barriers significantly impede access to pediatric HIV care.
- Caregivers' need for secrecy due to stigma and discrimination, coupled with misconceptions about childhood HIV, leads to delayed care-seeking.
- Poor access to healthcare and rural poverty were identified as contributing factors.
Conclusions:
- Addressing pediatric HIV care barriers requires multifaceted interventions, including awareness campaigns, improved healthcare access, and socioeconomic development initiatives.
- Enhanced training for healthcare professionals is recommended to improve attitudes and practices towards pediatric HIV care.
- Further research involving healthcare providers is necessary to complement caregiver perspectives for comprehensive policy and practice guidance.
Abstract:
In South Africa, a third of children born are exposed to HIV, while fewer undergo an HIV confirmatory test. Anti-retroviral therapy (ART) coverage among children remains low-despite roll-out of the national ART programme in South Africa in 2004. This study sought to understand critical barriers to seeking HIV-related care for children in rural South Africa. Data presented in this article derive from community-based qualitative research in poor rural villages in north-east South Africa; this includes 21 in-depth interviews in 2008 among caregivers of children identified as HIV-positive in 2007 from a randomly selected community-based sample. Using NVIVO 8, data were coded and analysed, using a constant comparative method to identify themes and their repetitions and variations. Structural barriers leading to poor access to health care, and social and systems barriers, all influenced paediatric HIV treatment seeking. Of concern was the expressed need to maintain secrecy regarding a child's HIV status to avoid stigma and discrimination, and misconceptions regarding the course of HIV disease in children; this led to a delay in seeking appropriate care. These barriers need to be addressed, including through focused awareness campaigns, improved access to health care and interventions to address rural poverty and development at both household and community levels. In addition, training of health care professionals to improve their attitudes and practice may be necessary. However, this study only provides the perspective of the caregivers; further studies with health care providers are needed to gain a fuller picture for appropriate policy and practice guidance.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Sexually Transmitted Infections
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Distribution

